Oncomedics

Oncomedics is a biotechnology company, part of CliniSciences Group, specializing in the personalization of cancer treatments. We are developing in vitro diagnostic medical devices that provide decision support to practitioners (surgeons, pathologists and oncologists) in order to identify the most effective treatments to cure a patient. What is the Oncogramme ? The Oncogramme predicts the anti-cancer activity of existing drugs by testing them directly on a patients operated tumor. Their efficacy is evaluated on a sample of this tumor ex vivo, using an approach comparable to that of the antibiogram. Since 2016, patients with stage IV colorectal cancer have been...

Cancer,personalised medicine,cancer treatment,preclinical study,clinical study,tumor,colorectal cancer,breast cancer,ovarian cancer,chemotherapy,oncogramme,pharma service,biotech service,and diagnostic

Oncomedics operates in the Biotechnology research industry.

Oncomedics's revenue is 11m - 100m

Oncomedics has 11 - 50 employees.